Premium
Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: A meta‐analysis
Author(s) -
Feng Li,
Deng Jin,
Huo DongMei,
Wu QiaoYuan,
Liao YunHua
Publication year - 2013
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/nep.12006
Subject(s) - medicine , lupus nephritis , azathioprine , mycophenolate , maintenance therapy , systemic lupus erythematosus , randomized controlled trial , dermatology , immunology , chemotherapy , disease , transplantation
The authors conducted a meta‐analysis of randomized controlled trials assessing the prognosis and safety of mycophenolate mofetil (MMF) versus azathioprine (AZA) used as maintenance therapy for lupus nephritis. Although the evidence was limited, they did derive a conclusion that MMF was as useful, or safer than AZA for maintenance therapy of lupus nephritis.